Medicare weight-loss drug coverage could overwhelm doctors

Next month's launch of a Medicare program providing weight-loss drugs for $50 a month is expected to unleash pent-up demand for Wegovy, Zepbound and other blockbuster treatments — and create new bottlenecks at doctors' offices. The big picture: It could become one of the biggest drug rollouts ever — and it could test an already burdened system as seniors seek new GLP-1 prescriptions. Clinicians worry that could also give short shrift to patient counseling on how to take the injectables and pills

Discussion

0 comments

Replying to cancel

GIF Post

Powered by

More from Axios

Boris Epshteyn: Trump's "psychiatrist" and counsel

Axios·8

"They screwed us": Personality clashes sent Anthropic's models offline

Axios·6

U.S., Iran reach deal to extend ceasefire, open strait

Axios·8

Trump to Axios: Netanyahu has "no fucking judgment" but Iran deal still on

Axios·8

Iran warns Israel's Beirut strike could derail U.S. deal

Axios·11

Cruz breaks with Trump on key endorsements as 2028 looms

Axios·10